Rewarding innovation in vaccine research

A nearly $200,000 grant from the Rhode Island Science and Technology Advisory Council allows researchers, including EpiVax Inc. founder Annie De Groot, above, to continue work on an anti-tick vaccine delivered through the use of a transdermal patch. De Groot has been working with University of Rhode Island researchers on the vaccine, which remains years away from the marketplace. The grant allows Isis Biopolymer Inc. to join in the project, to help develop a delivery system for the vaccine. More

This item is available in full to subscribers. If you are a current subscriber, log in to continue.

Otherwise, purchase a subscription to continue.

You can also purchase this single article, if you prefer. Click here to continue.